Global Health Advocates, together with STOPAIDS, commissioned a report series, exploring how a lack of transparency in the pharmaceutical industry and the European Union…
actionsantemondiale18 January 2023
After a year-long process, we’re pleased to publish our new 5-year strategy. On the road to 2030, we will focus on addressing two major challenges:…
actionsantemondiale17 January 2023
What should happen in 2023 to make progress in the fight against health inequalities? Our proposed good resolutions:Ensure the right to health everywhereNo more compromising…
actionsantemondiale1 January 2023
Today, the European Commission publishes its new EU Global Health Strategy (GHS), which replaces the Commission’s first and previous communication from 2010. Since its announcement,…
actionsantemondiale30 November 2022
Joint Statement on the Revision of the Pharmaceutical Legislation by associations representing healthcare providers, patients, healthcare professionals and payers Enhancing patients’ access to high-quality and affordable…
actionsantemondiale9 November 2022
The feedback for the European Commission’s public consultation about the renewal of its global health strategy (GHS) is now closed. We have been following this…
actionsantemondiale7 November 2022
The members of the European Alliance for Responsible R&D and Affordable Medicines have joint their voices in the Joint Rome Declaration to raise awareness and…
actionsantemondiale20 October 2022
The Covid-19 pandemic has highlighted the urgent need for collective actions and additional investment in pandemic prevention, preparedness, and response. To address the gaps, under…
actionsantemondiale7 October 2022
By Ella Weggen, Global health advocate at Wemos
actionsantemondiale28 September 2022
By Tilly Metz, Member of the EU Parliament
actionsantemondiale28 September 2022
;
